These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9627002

  • 1. Synthetic peptides fail to induce nasal tolerance to experimental autoimmune myasthenia gravis.
    Zhang GX, Shi FD, Zhu J, Xiao BG, Levi M, Wahren B, Yu LY, Link H.
    J Neuroimmunol; 1998 May 01; 85(1):96-101. PubMed ID: 9627002
    [Abstract] [Full Text] [Related]

  • 2. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD, Bai XF, Li HL, Huang YM, Van der Meide PH, Link H.
    Clin Exp Immunol; 1998 Mar 01; 111(3):506-12. PubMed ID: 9528890
    [Abstract] [Full Text] [Related]

  • 3. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor.
    Ma CG, Zhang GX, Xiao BG, Link J, Olsson T, Link H.
    J Neuroimmunol; 1995 Apr 01; 58(1):51-60. PubMed ID: 7537280
    [Abstract] [Full Text] [Related]

  • 4. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S, LeBoeuf RD, Blalock JE.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8747-51. PubMed ID: 8378359
    [Abstract] [Full Text] [Related]

  • 5. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY, Link H, Qiao J, Olsson T, Huang WX.
    J Neuroimmunol; 1993 Jun 15; 45(1-2):103-12. PubMed ID: 8331155
    [Abstract] [Full Text] [Related]

  • 6. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M, Oshima M, Atassi MZ, Christadoss P.
    Clin Immunol Immunopathol; 1993 Mar 15; 66(3):230-8. PubMed ID: 7679342
    [Abstract] [Full Text] [Related]

  • 7. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y, Lindstrom J.
    J Immunol; 1988 Mar 15; 140(6):1830-7. PubMed ID: 2450133
    [Abstract] [Full Text] [Related]

  • 8. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Huang J, Olsson T, He B, Link H.
    J Neurol Sci; 1995 Feb 15; 128(2):167-74. PubMed ID: 7537794
    [Abstract] [Full Text] [Related]

  • 9. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.
    Wang ZY, Qiao J, Link H.
    J Neuroimmunol; 1993 May 15; 44(2):209-14. PubMed ID: 8505410
    [Abstract] [Full Text] [Related]

  • 10. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG, Zhang GX, Xiao BG, Link H.
    Clin Exp Immunol; 1996 Jun 15; 104(3):509-16. PubMed ID: 9099937
    [Abstract] [Full Text] [Related]

  • 11. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX, Ma CG, Xiao BG, Bakhiet M, Link H, Olsson T.
    Eur J Immunol; 1995 May 15; 25(5):1191-8. PubMed ID: 7774622
    [Abstract] [Full Text] [Related]

  • 12. Modulation of anti-acetylcholine receptor antibody specificities and of experimental autoimmune myasthenia gravis by synthetic peptides.
    Souroujon MC, Carmon S, Fuchs S.
    Immunol Lett; 1992 Sep 15; 34(1):19-25. PubMed ID: 1282497
    [Abstract] [Full Text] [Related]

  • 13. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma.
    Li HL, Shi FD, Bai XF, Huang YM, van der Meide PH, Xiao BG, Link H.
    Clin Immunol Immunopathol; 1998 Apr 15; 87(1):15-22. PubMed ID: 9576006
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S, McIntosh K, Drachman DB.
    Ann Neurol; 1994 Nov 15; 36(5):704-13. PubMed ID: 7979216
    [Abstract] [Full Text] [Related]

  • 20. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD, Bai XF, Xiao BG, van der Meide PH, Link H.
    J Neurol Sci; 1998 Feb 18; 155(1):1-12. PubMed ID: 9562316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.